14-day Premium Trial Subscription Sign Up For FreeGet Free

Cerus Corporation Stock Forecast NASDAQ:CERS

Price Target and Analyst Ratings

Most Recent Rating

Cantor Fitzgerald is very positive about CERS and gave it a "Buy" rating on June 15, 2020. The price target was set to $9.00.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2020-06-15 Buy Initiated by Cantor Fitzgerald $6.30 $9.00
2020-05-27 Buy Target Raised by Stifel Nicolaus $5.95 $7.00 → $8.00
2020-04-16 Overweight Target Lowered by Stephens $5.14 $7.50 → $6.50

CERS Stock Trend

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 18.89% during the next 3 months and, with a 90% probability hold a price between $6.58 and $7.97 at the end of this 3-month period.

Data

Date Bottom Mid Top
2021-09-20 $5.55 $6.13 $6.72
2021-09-21 $5.57 $6.15 $6.74
2021-09-22 $5.58 $6.17 $6.75
2021-09-23 $5.60 $6.19 $6.77
2021-09-24 $5.62 $6.20 $6.79
2021-09-27 $5.64 $6.22 $6.80
2021-09-28 $5.65 $6.24 $6.82
2021-09-29 $5.67 $6.25 $6.84
2021-09-30 $5.69 $6.27 $6.85
2021-10-01 $5.70 $6.29 $6.87
2021-10-04 $5.72 $6.30 $6.89
2021-10-05 $5.74 $6.32 $6.90
2021-10-06 $5.75 $6.34 $6.92
2021-10-07 $5.77 $6.35 $6.94
2021-10-08 $5.79 $6.37 $6.96
2021-10-11 $5.80 $6.39 $6.97
2021-10-12 $5.82 $6.41 $6.99
2021-10-13 $5.84 $6.42 $7.01
2021-10-14 $5.85 $6.44 $7.02
2021-10-15 $5.87 $6.46 $7.04
2021-10-18 $5.89 $6.47 $7.06
2021-10-19 $5.91 $6.49 $7.07
2021-10-20 $5.92 $6.51 $7.09
2021-10-21 $5.94 $6.52 $7.11
2021-10-22 $5.96 $6.54 $7.12
2021-10-25 $5.97 $6.56 $7.14
2021-10-26 $5.99 $6.57 $7.16
2021-10-27 $6.01 $6.59 $7.18
2021-10-28 $6.02 $6.61 $7.19
2021-10-29 $6.04 $6.63 $7.21

About Cerus Corporation

Cerus Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System is based on its proprietary technology for controlling biological replication; and targets and inactivates blood-borne pathogens, including viruses, bacteria, and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, an... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT